Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
INTEGRIS Nazih Zuhdi Transplant Institute
mi
from
Oklahoma City, OK
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
INTEGRIS Nazih Zuhdi Transplant Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of California-Davis
mi
from
Sacramento, CA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
California Pacific Medical Center
mi
from
San Francisco, CA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Florida Health Shands Hospital
mi
from
Gainesville, FL
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Florida Health Shands Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Louisville
mi
from
Louisville, KY
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Erie County Medical Center
mi
from
Buffalo, NY
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Erie County Medical Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
SUNY Upstate NY University Hospital
mi
from
Syracuse, NY
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
SUNY Upstate NY University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Baylor All Saints
mi
from
Fort Worth, TX
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Baylor All Saints
mi
from
Fort Worth, TX
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Hospital Universitario Austral
mi
from
Buenos Aires,
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Hospital Universitario Austral
mi
from
Buenos Aires,
Click here to add this to my saved trials
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated:  12/31/1969
Georgetown Transplant Institute
mi
from
Washington,
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Status: Enrolling
Updated: 12/31/1969
Georgetown Transplant Institute
mi
from
Washington,
Click here to add this to my saved trials
Physical Activity Interventions for Leg Ulcer Patients
Physical Activity Interventions for Leg Ulcer Patients
Status: Enrolling
Updated:  12/31/1969
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Physical Activity Interventions for Leg Ulcer Patients
Physical Activity Interventions for Leg Ulcer Patients
Status: Enrolling
Updated: 12/31/1969
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
Combining Lovastatin and a Parent-Implemented Language Intervention in a Multimodal Treatment for Fragile X Syndrome
Status: Enrolling
Updated:  12/31/1969
UC Davis MIND Institute
mi
from
Sacramento, CA
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
Combining Lovastatin and a Parent-Implemented Language Intervention in a Multimodal Treatment for Fragile X Syndrome
Status: Enrolling
Updated: 12/31/1969
UC Davis MIND Institute
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Aiyan Diabetes Center
mi
from
Augusta, GA
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Aiyan Diabetes Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Salem VA Medical Center
mi
from
Salem, VA
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Salem VA Medical Center
mi
from
Salem, VA
Click here to add this to my saved trials
Oral Hygiene Intervention Pilot Study
Iowa Nursing Facility Oral Hygiene Intervention: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
UIowa
mi
from
Iowa City, IA
Oral Hygiene Intervention Pilot Study
Iowa Nursing Facility Oral Hygiene Intervention: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
UIowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
Prospective Evaluation of Patient-Reported Xerostomia After Whole Brain Radiation
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill, Department of Radiation Oncology
mi
from
Chapel Hill, NC
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
Prospective Evaluation of Patient-Reported Xerostomia After Whole Brain Radiation
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill, Department of Radiation Oncology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
TLC FIT: A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
TLC FIT: A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
TLC FIT: A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors
TLC FIT: A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent
Prospective, Randomized, Double-blind Controlled Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent at Skin Donor Sites
Status: Enrolling
Updated:  12/31/1969
San Antonio Military Medical Center
mi
from
San Antonio, TX
Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent
Prospective, Randomized, Double-blind Controlled Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent at Skin Donor Sites
Status: Enrolling
Updated: 12/31/1969
San Antonio Military Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)
Williams Syndrome Skin and Vascular Elasticity Study (WS-SAVE Study)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)
Williams Syndrome Skin and Vascular Elasticity Study (WS-SAVE Study)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluating the Efficacy of Opti-Speech for Speech Treatment
Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment
Status: Enrolling
Updated:  12/31/1969
The Cleveland Hearing and Speech Center
mi
from
Cleveland, OH
Evaluating the Efficacy of Opti-Speech for Speech Treatment
Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment
Status: Enrolling
Updated: 12/31/1969
The Cleveland Hearing and Speech Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating the Efficacy of Opti-Speech for Speech Treatment
Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment
Status: Enrolling
Updated:  12/31/1969
Callier Center for Communication Disorders at UT Dallas
mi
from
Richardson, TX
Evaluating the Efficacy of Opti-Speech for Speech Treatment
Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment
Status: Enrolling
Updated: 12/31/1969
Callier Center for Communication Disorders at UT Dallas
mi
from
Richardson, TX
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Long Beach, CA
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Farmington Hills, MI
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Berlin, NJ
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
New York, NY
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
Theravance Biopharma Investigational Site
mi
from
Nashville, TN
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials